C2 (Rubraca 200 mg)
Generic Name: rucaparib
Pill with imprint C2 is Blue, Round and has been identified as Rubraca 200 mg. It is supplied by Clovis Oncology, Inc..
Rubraca is used in the treatment of ovarian cancer; prostate cancer and belongs to the drug class PARP inhibitors. Rubraca 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C2
Rubraca
- Generic Name
- rucaparib
- Imprint
- C2
- Strength
- 200 mg
- Color
- Blue
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Parp inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Clovis Oncology, Inc.
- National Drug Code (NDC)
- 69660-0201
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type A potato,
silicon dioxide,
magnesium stearate,
titanium dioxide,
magnesium silicate,
FD&C Blue No. 1,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related Images for "C2"
More about Rubraca (rucaparib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: PARP inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.